59830-38-5Relevant academic research and scientific papers
Synthesis of the key intermediate of coenzyme Q10
Mu, Fan-Song,Luo, Meng,Fu, Yu-Jie,Zhang, Xuan,Yu, Ping,Zu, Yuan-Gang
, p. 4097 - 4103 (2011)
(2′E)-1-(3-methyl-4-p-toluenesulfonyl-2-butene)-6-methyl-2,3,4, 5-tetramethoxybenzene (4) is the key intermediate in the synthesis of coenzyme Q10via a coupling reaction with solanesyl bromide. In this paper, we report a simple and effective synthesis of
Synthesis of (±)- and (-)-botryodiplodin using stereoselective radical cyclizations of acyclic esters and acetals
Nouguier, Robert,Gastaldi, Stephane,Stien, Didier,Bertrand, Michele,Villar, Felix,Andrey, Olivier,Renaud, Philippe
, p. 3005 - 3018 (2007/10/03)
Three different routes for the stereoselective synthesis of botryodiplodin have been investigated. The intramolecular allylation of acetals proved to be unsatisfactory due to unstable intermediates and poor stereocontrol. Zard intramolecular radical allyl
Intramolecular radical allylation with allylic sulfones a synthesis of (±)-botryodiplodin
Nouguier, Robert,Gastaldi, Stephane,Stien, Didier,Bertrand, Michele,Renaud, Philippe
, p. 3371 - 3374 (2007/10/03)
Isopropenyl-5-membered-ring acetal or lactone are potential precursors of (±)-botryodiplodin (1). Several pathways, involving 5-exo-trig ring closure onto allylic sulfones, have been investigated. The iodine atom transfer methodology allowed the preparati
Synthesen von Carotinen mit ψ-Endgruppen und (Z)-Konfiguration an terminalen konjugierten Doppelbindungen
Zumbrunn, Albrecht,Uebelhart, Peter,Eugster, Conrad Hans
, p. 1519 - 1539 (2007/10/02)
Five carotenes bearing (5Z)-ψ-end groups were synthesized and carefully characterized: (5Z)-lycopene (6), (5Z,5'Z)-lycopene (7), (5'Z)-neurosporene (8), (5'Z)-β,ψ-carotene (12), and (5'Z)-εψ-carotene (14).
Process for producing a sulfone derivative of vitamin A alcohol
-
, (2008/06/13)
A process for the preparation of vitamin A and esters thereof from the condensation of a sulfone of 2-methyl-4-hydroxy-but-2-ene and an activated derivative of 3-methyl-5-(2,6,6-trimethyl-cyclohexen-1-yl)penta-2,4-diene including intermediates therein.
